amikacin has been researched along with ro13-9904 in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (11.00) | 18.7374 |
1990's | 33 (33.00) | 18.2507 |
2000's | 28 (28.00) | 29.6817 |
2010's | 17 (17.00) | 24.3611 |
2020's | 11 (11.00) | 2.80 |
Authors | Studies |
---|---|
Betti, S; D'Antonio, D; D'Arcangelo, L; Dell'Isola, M; Fioritoni, G; Iacone, A; Mastrangelo, C; Natale, D; Recchia, A; Spadano, A | 1 |
Bodmer, T; Garlando, F; Lee, C; Pirovino, M; Zimmerli, W | 1 |
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Micozzi, A; Raccah, R; Sgadari, C | 1 |
Fuchsberger, P; Horníková, M; Koza, I; Krcméry, V; Kusenda, Z; Mardiak, J; Spánik, S; Sufliarsky, J; Svec, J; Trupl, J | 1 |
Bodmer, T; Malinverni, R; Mathieu, R; Weiss, D | 1 |
Jeschko, M; Pedrazzini, A; Schafroth, U; Schmid, L; Senn, H; Thürlimann, B; Wilder-Smith, C | 1 |
Avlami, A; Meletis, J; Rombos, Y; Vayopoulos, G; Yataganas, X | 1 |
Bauters, F; Blanc, C; Pollet, JP | 1 |
Aoun, M; Ibrahim, S; Meunier, F; Tulkens, PM; Van der Auwera, P | 1 |
Cleeland, R; Prosser, BL; Taylor, DB | 1 |
Hanberger, H; Isaksson, B; Maller, R; Nilsson, LE; Nilsson, M | 1 |
Boulis, SA; Floras, GA; Kabbani, K; Lekkas, ET; Paizis, JB; Tsimoyiannis, EC | 1 |
Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
Aulicino, TM; Berkowitz, LB; duBouchet, L; Gombert, ME | 1 |
Aksebzeci, T; Fazli, SA | 1 |
Cantonetti, M; Criscuolo, D; Cudillo, L; Masi, M; Papa, G; Scimò, MT; Tribalto, M | 1 |
Liu, CY; Wang, FD | 1 |
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 2 |
Baron, D; Cozian, A; Espaze, E; Juge, C; Lepage, JY; Reynaud, AE; Souron, R | 1 |
Bigot, E; Caillon, J; Drugeon, HB; Juvin, ME | 1 |
Aguirre, X; Basauri, L; Prado, V; Zuleta, A | 1 |
Watanakunakorn, C | 1 |
Angehrn, P | 1 |
Bayer, AS; Eisenstadt, R; Morrison, JO | 1 |
Cavallo, JD; Chevalier, B; Meyran, M | 1 |
Akin, ES; Bilgiç, H; Ekiz, K; Seber, O; Taşan, Y | 1 |
Artiges, V; Bouffet, E; Bouhour, D; Brunat Mentigny, M; Charra, C; Couillioud, D; Frappaz, D; Fuhrmann, C | 1 |
Aswapokee, N; Chayakul, P; Chuncharunee, S; Leelasuphasri, S; Sathapatayavongs, B; Siritanaratkul, N; Suwangool, P | 1 |
Danisovicová, A; Drgona, L; Fuchsberger, P; Korec, S; Krcméry, V; Spánik, S; Svec, J | 1 |
Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C | 1 |
Chéron, G; Gaillard, JL; Labenne, M; Lacaille, F; Le Masne, A; Pron, B; Silly, C | 1 |
Charnas, R; Lüthi, AR; Ruch, W | 1 |
Curati, W; Lynn, WA; McLaughlin, JE; Ogg, G; Peters, M; Shaunak, S | 1 |
Bangtrakulnonth, A; Boonmar, S; Kaneko, K; Ogawa, M; Pornruangwong, S; Samosornsuk, S | 1 |
Alfurayh, O; Alrabiah, F; Hassounah, M; Sabeel, A | 1 |
Gonzalez-Torres, C; Jiménez-Valera, M; Moreno, E; Ruiz-Bravo, A | 1 |
Castagnola, E; Dini, G; Giacchino, R; Lanino, E; Viscoli, C | 1 |
Hubbard, RW; Slocum, R | 1 |
Alimena, G; Battistini, R; Breccia, M; Celesti, F; Cimino, G; Coppola, L; Girmenia, C; Latagliata, R; Mandelli, F; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
Adams, C; Ghazali, D; Le Loc'h, H; Leturdu, F; Sarda, H; Thibault, M | 1 |
Cometta, A; De Bock, R; Gaya, H; Kern, WV; Langenaeken, J; Paesmans, M | 1 |
Alimena, G; Celesti, F; Cimino, G; Coppola, L; D'Elia, GM; Girmenia, C; Latagliata, R; Mandelli, F; Mecarocci, S; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
Hoh, HB; Kamarulzaman, A; Tan, LH; Tan, SY; Teo, SM; Thiruventhiran, T | 1 |
Arasu, A; Ariffin, H; Ariffin, WA; Chan, LL; Lin, HP; Mahfuzah, M | 1 |
Citak, A; Garratty, G; Karabocuoglu, M; Ucsel, R; Uzel, N | 1 |
Calleja, J; Flores, G; Magaña, F; Nellen, H | 1 |
de André Júnior, LS; de Resende, MV; Schmidt, ML; Vieira, ML | 1 |
Casimir, L; Debbag, R; Fraquelli, L; Gómez, S; Iturres, AS; Latella, A; Paganini, H; Ruvinsky, S; Zubizarreta, P | 1 |
Bodmer, T; Fux, C; Leib, SL; Ziswiler, HR | 1 |
Cypriano, M; Dantas, LS; Lee, LM; Petrilli, AS; Pires Pereira, CA; Torres B Silva, KV; Vercillo Luisi, MF | 1 |
Gazanfar, A; Hassan, G; Kadri, SM; Kak, M; Khan, GQ; Shahid, IT; Showkat, H | 1 |
Abdulkadyrov, KM; Chebotkevich, VN; Chudanova, TV | 1 |
Ayar, M; Crevon, T; Falque, L; Herve, V; Koninck, JC; L'Her, P; Le Vagueresse, R; Samson, T; Simon, F; Vaylet, F | 1 |
Güven, A | 1 |
Giltri, G; Isella, M; Larocca, A; Marinoni, S; Miccolis, I; Parma, M; Pogliani, EM; Rossini, F; Terruzzi, E; Verga, L | 1 |
Alp, E; Aygen, B; Boiron, P; Couble, A; Doganay, M; Sumerkan, B; Tokgoz, B; Tucer, B; Yildiz, O | 1 |
Deotale, V; Mendiratta, DK; Narang, P | 1 |
Arch, J; González, QH; Hinojosa, C; Medina-Franco, H; Orozco, H; Pantoja, JP; Sifuentes-Osornio, J; Vargas-Vorackova, F; Vilatoba, M | 1 |
Ghalib, MB; Hassan, IS | 1 |
Acar, B; Aysev, D; Ekim, M; Güriz, H; Kavaz, A; Ozçakar, ZB; Oztürk, B; Yalçinkaya, F; Yüksel, S | 1 |
Arya, SC; Mathai, G; Mehta, LK | 1 |
Ahmed, IA; Ahmed, N; El-Beshlawy, A; El-Haddad, A; El-Mahallawy, HA; Nassif, S | 1 |
Rosoff, PM; Saini, S | 1 |
Cappabianca, P; de Divitiis, E; Esposito, F; Orlando, R; Piazza, M; Tosone, G | 1 |
Ivanova, VS; Lebedeva, SA; Morozova, IV | 1 |
Béraud, G; Iba Ba, J; Legout, L; Mouton, Y; Senneville, E; Yazdanpanah, Y | 1 |
Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B | 1 |
Carlesse, FA; da Silva, KV; de Martino Lee, ML; Luisi, FA; Pereira, CA; Petrilli, AS | 1 |
Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C | 1 |
Gajardo S, C; Le Corre P, N; Montecinos B, C; Morales M, V; Peña D, A; Viviani S, T | 1 |
Atapour, AA; Beigi, AA; Eshaghian, A; Khademi, EF; Khansoltani, S; Masoudpour, H | 1 |
Agarwal, A; Belokar, WK; Hirachan, S; Karmacharya, A; Praveen, CR | 1 |
Guzmán-Sánchez, C; Luna-Lugo, G | 1 |
Fredrick, F; Massawe, A; Matee, MI; Mhada, TV | 1 |
Apter, S; Eviatar, T; Grossman, E; Hoffman, C; Keller, N; Rosman, Y; Thaler, M | 1 |
Alidjinou, EK; Bonnet, I; Canis, F; Cattoen, C; Dewulf, G; Mazars, E | 1 |
Chen, YX; Hu, GZ; Liu, JH; Pan, YS; Wu, H; Yuan, L | 1 |
Fisher, MA; Hanson, KE; Schlaberg, R | 1 |
Cicero, A; Colin, C; Franco-Cendejas, R; Hernández, M; López-Jácome, E; Vanegas, S | 1 |
Karthik, H; Lake, SR; Richards, AD; Stewart, C | 1 |
Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Chaudhry, T; Gilson, A; Gollogly, J; Kennedy, K; Mony, K; Noor, S; Swanson, A; Vanny, V | 1 |
Barbui, A; Caligaris, S; Castelli, F; Chiari, E; Grecchi, C; Gulletta, M; Matteelli, A; Pontarelli, A; Tomasoni, LR; Zanotti, P | 1 |
Andrey, DO; Banerjee, M; Farzana, R; Jones, LS; Pervin, M; Portal, E; Rahman, MA; Sands, K; Walsh, TR; Watkins, WJ | 1 |
Beliavsky, A; Bernick, J; Bogoch, II | 1 |
Al-Zaban, MI; AlHarbi, MA; Azim, NSA; Nofal, MY; Somily, AM | 1 |
Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T | 1 |
Mylle, J; Mylle, S; Mylle, T | 1 |
Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C | 1 |
Chen, CH; Chen, NY; Chiu, CH; Chung, WH; Lai, HC; Lao, CK; Lee, CH; Liu, TP; Lu, JJ; Tseng, MC; Wu, TS; Yang, LY | 1 |
Bond, K; Globan, M; Lea, K; Naimo, P; Williamson, DA; Yeoh, K | 1 |
Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A | 1 |
Abdul Ameer Al-Kraety, I; Ghani Al-Muhanna, S; Maki N Al-Muaala, A; Sadeq Yasir Al-Ethari, A | 1 |
Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A | 1 |
Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
Adeleke, G; Egbagbe, E; Ejembi, J; Ettu, AO; Habib, A; Irowa, OO; Makanjuola, OB; Medugu, N; Mutiu, B; Ogunbosi, B; Ogunsola, F; Oladele, RO; Osinaike, T; Rotimi, V; Uwaezuoke, NS | 1 |
2 review(s) available for amikacin and ro13-9904
Article | Year |
---|---|
Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature.
Topics: Adult; Amikacin; Cardiotonic Agents; Ceftriaxone; Diabetes Mellitus, Type 2; Dopamine; Emphysema; Female; Fluid Therapy; Humans; Hypoglycemic Agents; Insulin; Pyelonephritis; Radiography; Treatment Outcome | 2002 |
Salmonella typhi endocarditis: a case report.
Topics: Adult; Amikacin; Aortic Valve; Ceftriaxone; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Heart Valve Diseases; Humans; Male; Salmonella typhi; Typhoid Fever | 2003 |
24 trial(s) available for amikacin and ro13-9904
Article | Year |
---|---|
Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation.
Topics: Adult; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male | 1992 |
Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neoplasms | 1991 |
Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia | 1991 |
Short-term antibiotic prophylaxis in elective colorectal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Colorectal Neoplasms; Costs and Cost Analysis; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Ornidazole; Premedication; Prospective Studies | 1991 |
A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Random Allocation; Remission Induction | 1989 |
[Comparative study of first-line ceftriaxone and amikacin in the treatment of severe urinary tract infections in the adult].
Topics: Adult; Aged; Amikacin; Ceftriaxone; Drug Evaluation; Drug Tolerance; Humans; Middle Aged; Random Allocation; Urinary Tract Infections | 1987 |
Once daily antibiotic regimen in paediatric oncology.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Humans; Infant; Neoplasms; Teicoplanin; Vancomycin | 1994 |
Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
Topics: Adolescent; Adult; Aged; Amikacin; Ceftriaxone; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Sepsis | 1993 |
Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the Eu
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ear Diseases; Female; Humans; Infant, Newborn; Infections; Kidney Diseases; Male; Middle Aged; Neoplasms; Prospective Studies; Treatment Outcome | 1993 |
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection | 1995 |
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia | 1997 |
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Amoxicillin; Antineoplastic Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Prospective Studies; Survival Rate | 1999 |
Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Multivariate Analysis; Neoplasms; Neutropenia; Prospective Studies; Statistics, Nonparametric | 2001 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Argentina; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Infant; Leukemia; Male; Neutropenia; Risk | 2003 |
Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.
Topics: Adolescent; Amikacin; Bacterial Infections; Brazil; Ceftriaxone; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Epidemiologic Methods; Female; Fever; Humans; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neutropenia; Ticarcillin; Treatment Outcome | 2003 |
[Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukocyte Count; Neutropenia; Neutrophils; Time Factors; Treatment Outcome | 2003 |
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2005 |
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Peritonitis; Recombinant Proteins; Sepsis; Survival Rate; Treatment Outcome | 2006 |
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Sepsis; Time Factors | 2007 |
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Fever; Greece; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 2008 |
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Male; Neutropenia; Treatment Outcome; Young Adult | 2009 |
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome | 2009 |
[Treatment of urinary tract infections in febrile infants: experience of outpatient intravenous antibiotic treatment].
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Female; Fever; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Medication Adherence; Prospective Studies; Time Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Ceftriaxone; Device Removal; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Kidney Failure, Chronic; Male; Prospective Studies; Renal Dialysis; Treatment Outcome; Vancomycin | 2010 |
74 other study(ies) available for amikacin and ro13-9904
Article | Year |
---|---|
Successful treatment of disseminated nocardiosis complicated by cerebral abscess with ceftriaxone and amikacin: case report.
Topics: Aged; Aged, 80 and over; Amikacin; Brain Abscess; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Nocardia asteroides; Nocardia Infections | 1992 |
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies.
Topics: Adolescent; Adult; Aged; Amikacin; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Day Care, Medical; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Pilot Projects | 1992 |
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Netilmicin; Retrospective Studies | 1992 |
[Systemic Nocardia infection in an AIDS patient].
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Ceftriaxone; Drug Therapy, Combination; Humans; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Sarcoma, Kaposi | 1992 |
Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftriaxone; Child; Drug Therapy, Combination; Humans; Leukemia; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia | 1991 |
Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Pilot Projects; Vancomycin | 1991 |
In vitro activity of ceftriaxone and amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Ceftriaxone; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1991 |
Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Piperacillin; Streptococcal Infections | 1991 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
Therapy of pulmonary nocardiosis in immunocompromised mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cortisone; Female; Humans; Imipenem; Immunity, Cellular; Immunologic Deficiency Syndromes; Lung Diseases; Mice; Nocardia asteroides; Nocardia Infections; Sulfadiazine | 1990 |
[Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Escherichia coli; Humans; Klebsiella; Netilmicin; Piperacillin; Proteus; Pseudomonas; Staphylococcus | 1989 |
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Humans; Middle Aged | 1989 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
[Bactericidal activity of ceftriaxone, amikacin and their combination].
Topics: Amikacin; Bacteria; Ceftriaxone; Drug Combinations; Microbial Sensitivity Tests | 1986 |
[Ceftriaxone by systemic route combined with amikacin by intraventricular route in the treatment of ventriculitis in children with hydrocephalus].
Topics: Amikacin; Cefotaxime; Ceftriaxone; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Drug Therapy, Combination; Encephalitis; Humans; Hydrocephalus; Injections, Intraventricular; Kanamycin | 1984 |
In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefotaxime; Ceftriaxone; Drug Synergism; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1983 |
In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Leukopenia; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1983 |
Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
Topics: Amikacin; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Kanamycin; Time Factors | 1984 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
A case of Acinetobacter calcoaceticus pneumonia.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Amikacin; Ceftriaxone; Community-Acquired Infections; Diagnosis, Differential; Humans; Male; Pneumonia, Bacterial | 1995 |
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
Topics: Amikacin; Antineoplastic Agents; Bacterial Infections; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Hearing; Humans; Kidney; Leukemia; Lymphoma; Neutropenia; Retrospective Studies | 1993 |
[Pneumococcal meningitis in children: should probabilistic antibiotherapy of infectious meningitis be modified?].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Male; Meningitis, Pneumococcal; Netilmicin; Penicillin Resistance; Probability; Retrospective Studies | 1996 |
Cerebral nocardia abscesses in a patient with AIDS: correlation of magnetic resonance and white cell scanning images with neuropathological findings.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Magnetic Resonance Imaging; Male; Nocardia asteroides; Nocardia Infections; Radionuclide Imaging; Thienamycins | 1997 |
Significant increase in antibiotic resistance of Salmonella isolates from human beings and chicken meat in Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Chickens; Child; Child, Preschool; Drug Resistance, Microbial; Female; Gentamicins; Humans; Infant; Kanamycin; Male; Meat; Middle Aged; Nalidixic Acid; Salmonella; Salmonella Infections; Thailand | 1998 |
Nocardial brain abscess in a renal transplant recipient successfully treated with triple antimicrobials.
Topics: Amikacin; Brain Abscess; Ceftriaxone; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Feces; Female; Intestinal Diseases; Mice; Mice, Inbred BALB C; Yersinia enterocolitica; Yersinia Infections | 1998 |
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
Topics: Adolescent; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost Control; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome | 1999 |
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin | 1995 |
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy.
Topics: Adult; Aged; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Cross Infection; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fever; Hospitalization; Humans; Idarubicin; Incidence; Length of Stay; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Tretinoin | 1999 |
[Multifocal invasive Kingella kingae infection].
Topics: Amikacin; Amoxicillin; Arthritis, Infectious; Bacteremia; Ceftriaxone; Child, Preschool; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Female; Humans; Infant; Kingella kingae; Meningitis, Bacterial; Neisseriaceae Infections | 1998 |
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Topics: Adult; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Clinical Trials as Topic; Drug Therapy, Combination; Emergency Service, Hospital; Fever; Hospitalization; Humans; Immunocompromised Host; Italy; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Mycoses; Neutropenia; Staphylococcal Infections | 1999 |
Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient.
Topics: Adult; Amikacin; Cataract; Cataract Extraction; Ceftriaxone; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Nocardia Infections; Postoperative Complications; Transplantation, Homologous; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
Topics: Amikacin; Anemia, Hemolytic; Antigen-Antibody Complex; Ceftriaxone; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Methylprednisolone; United States; Urinary Tract Infections | 2002 |
Multiple embolism in a female patient with infective endocarditis. Low back pain and hematuria as the initial clinical manifestations.
Topics: Amikacin; Ceftriaxone; Cephalosporins; Embolism; Endocarditis, Bacterial; Female; Hematuria; Humans; Low Back Pain; Middle Aged; Mitral Valve Prolapse; Streptococcus; Vancomycin | 2002 |
[Nocardia cyriacigeorgici: First report of invasive human infection].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; DNA, Ribosomal; Drainage; Humans; Immunocompromised Host; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Sequence Homology, Nucleic Acid; Thienamycins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
[Thoracic nocardiasis associated with macrophage activation syndrome].
Topics: AIDS-Related Opportunistic Infections; Amikacin; Arthritis, Infectious; Biopsy; Bone Marrow; Ceftriaxone; Diagnosis, Differential; Drug Resistance, Multiple; Drug Therapy, Combination; Histiocytosis, Non-Langerhans-Cell; Humans; Lung; Macrophage Activation; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia, Bacterial; Recurrence; Synovial Membrane; Systemic Inflammatory Response Syndrome; Tomography, X-Ray Computed | 2001 |
Intramuscular antibiotic treatment of urinary tract infection.
Topics: Amikacin; Analysis of Variance; Anti-Infective Agents, Urinary; Ceftriaxone; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Male; Probability; Prospective Studies; Severity of Illness Index; Treatment Outcome; Turkey; Urinalysis; Urinary Tract Infections | 2004 |
Nocardiosis in a teaching hospital in the Central Anatolia region of Turkey: treatment and outcome.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Causality; Ceftriaxone; Fatal Outcome; Female; Hospitals, Teaching; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Retrospective Studies; Turkey | 2005 |
Metallo-beta-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area.
Topics: Amikacin; beta-Lactamases; Ceftazidime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Gentamicins; Hospitals, Rural; Imipenem; India; Pseudomonas aeruginosa; Species Specificity | 2005 |
Prolonged unconsciousness in a patient with End-stage Renal Disease.
Topics: Aged; Amikacin; Brain Abscess; Brain Diseases; Brain Edema; Ceftriaxone; Humans; Kidney Failure, Chronic; Male; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Unconsciousness; Vancomycin | 2006 |
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Topics: Adolescent; Age Factors; Amikacin; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2006 |
Infarction of spleen in typhoid fever.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Follow-Up Studies; Humans; Male; Risk Assessment; Salmonella typhi; Severity of Illness Index; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome; Typhoid Fever; Ultrasonography, Doppler | 2007 |
Are we finally ready for outpatient management of febrile neutropenia?
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Monitoring, Physiologic; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Safety Management; Sepsis; Time Factors | 2007 |
Retrospective analysis of a new antibiotic chemoprophylaxis regimen in 170 patients undergoing endoscopic endonasal transsphenoidal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Ceftriaxone; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Female; Humans; Male; Middle Aged; Nasal Cavity; Retrospective Studies; Surgical Wound Infection | 2007 |
[Resistance of experimental antibiotic resistant variants of Yersinia pestis EV76 (NIIEG line) to modern marker antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Doxycycline; Drug Resistance, Multiple, Bacterial; Yersinia pestis | 2006 |
[Primary Salmonella vascular graft infection and conservative treatment].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Cefotaxime; Ceftriaxone; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Femoral Artery; Humans; Laparotomy; Male; Ofloxacin; Oxacillin; Popliteal Artery; Prosthesis-Related Infections; Recurrence; Salmonella Infections; Salmonella typhimurium; Shock, Septic | 2008 |
Prostatic abscess a diagnostic dilemma.
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Diagnosis, Differential; Dysuria; Humans; Male; Middle Aged; Prostate; Prostatic Diseases; Ultrasonography; Urinary Retention | 2010 |
[Transcesarean ileal resection of double Meckel diverticulum].
Topics: Adult; Amikacin; Anastomosis, Surgical; Anti-Bacterial Agents; Ceftriaxone; Cesarean Section, Repeat; Drug Therapy, Combination; Female; Humans; Ileum; Infant, Newborn; Male; Meckel Diverticulum; Pregnancy | 2011 |
Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome.
Topics: Amikacin; Ampicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cloxacillin; Escherichia coli; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella; Male; Microbial Sensitivity Tests; Sepsis; Staphylococcus aureus; Tanzania; Treatment Outcome | 2012 |
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amikacin; Carbapenems; Ceftriaxone; Cohort Studies; Encephalitis; Female; Humans; Immunocompromised Host; Israel; Male; Middle Aged; Nocardia Infections; Pleuropneumonia; Retrospective Studies; Risk Factors; Skin Diseases, Bacterial; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
[Gardnerella vaginalis bacteremia in a male patient].
Topics: Adenocarcinoma; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftriaxone; Chemotherapy, Adjuvant; Colostomy; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Middle Aged; Peritoneal Neoplasms; Sigmoid Neoplasms | 2013 |
Genetic variations in the active efflux pump genes acrA/B and tolC in different drug-induced strains of Escherichia coli CVCC 1547.
Topics: Amikacin; Bacterial Outer Membrane Proteins; Ceftriaxone; Ciprofloxacin; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Lipoproteins; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation, Missense; Sequence Analysis, DNA | 2013 |
Susceptibility profiles of Nocardia isolates based on current taxonomy.
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Oxazolidinones; Phylogeny; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Nocardia brasiliensis-associated femorotibial osteomyelitis.
Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Female; Humans; Imipenem; Nocardia; Nocardia Infections; Osteomyelitis; Phylogeny; Specimen Handling; Sulfamethoxazole; Trimethoprim; Young Adult | 2014 |
Bilateral subretinal abscesses: the first case of disseminated Nocardia beijingensis in Australia.
Topics: Abscess; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Native Hawaiian or Other Pacific Islander; Nocardia; Nocardia Infections; Retinal Diseases; Trimethoprim, Sulfamethoxazole Drug Combination; Vitrectomy | 2015 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Pre-packing of cost effective antibiotic cement beads for the treatment of traumatic osteomyelitis in the developing world - an in-vitro study based in Cambodia.
Topics: Amikacin; Anti-Bacterial Agents; Bone Cements; Cambodia; Ceftriaxone; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Fractures, Open; Gentamicins; Humans; Microspheres; Osteomyelitis; Polymethyl Methacrylate; Vancomycin | 2016 |
Louse-borne relapsing fever in a refugee from Mali.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Borrelia; Ceftriaxone; DNA, Bacterial; Doxycycline; Humans; Italy; Libya; Male; Mali; Pediculus; Refugees; Relapsing Fever; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treatment Outcome; Young Adult | 2017 |
Outbreak of Hypervirulent Multidrug-resistant Klebsiella variicola Causing High Mortality in Neonates in Bangladesh.
Topics: Amikacin; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Ceftriaxone; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Plasmids; Survival Analysis | 2019 |
Endometritis and Bacteremia With a New Delhi Metallo-Beta-Lactamase 1 (NDM-1)-containing Organism in a Remote Traveler.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftriaxone; Cesarean Section; Drug Resistance, Bacterial; Endometritis; Escherichia coli; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Humans; India; Nucleic Acid Amplification Techniques; Ontario; Pregnancy; Pregnancy, Twin; Puerperal Infection; Travel | 2019 |
Molecular-diversity, Prevalence and Antibiotic Susceptibility of Pathogenic Klebsiella Pneumoniae under Saudi Condition.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; DNA, Bacterial; Female; Genetic Variation; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Virulence | 2019 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors | 2020 |
Nocardia Farcinica infection of a reversed shoulder prosthesis : case report and review.
Topics: Administration, Intravenous; Aged; Amikacin; Anti-Bacterial Agents; Arthroplasty, Replacement, Shoulder; Ceftriaxone; Female; Humans; Nocardia; Nocardia Infections; Prosthesis-Related Infections; Reoperation; Shoulder Prosthesis; Treatment Outcome | 2020 |
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Humans; Imipenem; Immunosuppressive Agents; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Taiwan; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Identification and antimicrobial susceptibility of referred
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Victoria | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
Genotypic Detection of
Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Molecular Detection of
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2022 |
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosfamide; Imipenem; Linezolid; Microbial Sensitivity Tests; Mycetoma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Critical Illness; Cross Infection; Fluconazole; Humans; Meropenem; Microbial Sensitivity Tests; Nigeria; Piperacillin, Tazobactam Drug Combination; Pneumonia; Prospective Studies; Urinary Tract Infections | 2023 |